Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why can't you just look up the filings yourself?
Next monday could be big- keep in mind its a friday, weekend sellers
The house collapsed from the weight of the paint
Not much of a paint job considering it was 2.5 mil :)
Interesting- 36 buy went through but my level 2 was still showing 33 at the ask
O/S won't change. Those shares are in reserve and will simply be put back in treasury
Real time quote? My etrade mobile app won't load
MINE is back in business :)
Absolutely ecstatic
Bye bye 34
.04 today? Possible!
Well you could always go on their website and look at the locator
Looks like you're gonna be right!
From the attention that MINE seems to have gathered from yesterdays news, we could easily see a verry green day
Little bit of fluctuation today. My guess just some profit takers from yesterdays big % gain. Millions in revenue means only green from here
Possibly just asher clearing out any shares they might have left after the prepay
Somebody either doesn't know how to read or is purposely misreading it
If you are considering buying in- reread the PR. Millions of dollars in orders each month! BUYBUYBUY!
Huh?
Could see .05 today easy
Hahahahaaah
Awesome- last of the toxic debt is GONE!
link?
Lol, its about as definite as a PR can get! Ha
PAWS acquires MULTI MILLION DOLLAR PHARMACEUTICAL COMPANY
The PAWS Pet Company, Inc. Executes Agreement to Acquire MESA Pharmacy, Inc. Orders expected to exceed $25 Million in 2014
Date : 10/29/2013 @ 4:36PM
Source : PR Newswire (US)
Stock : Paws Pet Company, Inc. (QB) (PAWS)
Quote : 0.0258 0.0092 (55.42%) @ 4:30PM
The PAWS Pet Company, Inc. Executes Agreement to Acquire MESA Pharmacy, Inc. Orders expected to exceed $25 Million in 2014
Print
Alert
Paws Pet Company, Inc. (QB) (USOTC:PAWS)
Intraday Stock Chart
Today : Tuesday 29 October 2013
Click Here for more Paws Pet Company, Inc. (QB) Charts.
The PAWS Pet Company, Inc. (OTCQB:PAWS), announced it has executed an agreement to acquire MESA Pharmacy, Inc. as part of its new strategy to become a dominant player in the delivery of compounded pharmaceutical products to consumers.
PALO ALTO, CA, Oct. 29, 2013 /PRNewswire/ - The PAWS Pet Company, Inc. (OTCQB:PAWS) has executed an agreement to acquire MESA Pharmacy, Inc. (MESA) from its parent, Pharmacy Development Corp. in exchange for preferred stock. PAWS will be filing a report on Form 8-K within the next few days. Previously, the Company had announced that it and PDC had determined to enter into a joint venture, however progress on PDC/MESA's audit has been much better than anticipated and the parties have determined that purchasing MESA would be better for all of the parties and their respective shareholders.
MESA focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and clinics. MESA has developed a series of topical ointments, in different strengths, that provide the pain relief doctors seek.
During the current month, according to MESA, it has received more than $3,400,000 in orders and filled more than $1,500,000 in actual prescriptions. MESA believes that it is on track to exceed $25,000,000 in revenues during fiscal year 2014 with much greater revenues a very real possibility.
PDC will be paid a royalty on collection for each prescription filled by MESA as well as receiving 500,000 shares of PAWS Series D Convertible Preferred Stock. The parties will begin the process of transferring MESA's license from PDC to PAWS as soon as possible and the transaction is intended to close upon the issuance of a new California pharmacy license or sooner. PDC has the right to appoint three members to the Board of Directors as soon as the new license is issued and the audit of MESA's operations is completed.
Furthermore, the holders of a majority of the Company's Series B Convertible Preferred Stock shares have agreed to vote to reduce the maximum conversion rate in order to offset the new Series D stock, on a fully diluted basis.
Additionally, PAWS intends to spin off its remaining airline related properties, freeing the Company of much of its debt and further intends to settle most of its remaining debt in the very near future.
"We are excited about these developments, for our company and our shareholders, and we believe with MESA's great team, a great foundation for future growth is set", said Dan Wiesel CEO of The PAWS Pet Company. He continued, "With the execution of this agreement, the way forward for PAWS is clear and we will now focus on completing the licensing process, domesticating the Company in Nevada and changing our name to Praxsyn Corporation."
PAWS acquires MULTI MILLION DOLLAR PHARMACEUTICAL COMPANY
The PAWS Pet Company, Inc. Executes Agreement to Acquire MESA Pharmacy, Inc. Orders expected to exceed $25 Million in 2014
Date : 10/29/2013 @ 4:36PM
Source : PR Newswire (US)
Stock : Paws Pet Company, Inc. (QB) (PAWS)
Quote : 0.0258 0.0092 (55.42%) @ 4:30PM
The PAWS Pet Company, Inc. Executes Agreement to Acquire MESA Pharmacy, Inc. Orders expected to exceed $25 Million in 2014
Print
Alert
Paws Pet Company, Inc. (QB) (USOTC:PAWS)
Intraday Stock Chart
Today : Tuesday 29 October 2013
Click Here for more Paws Pet Company, Inc. (QB) Charts.
The PAWS Pet Company, Inc. (OTCQB:PAWS), announced it has executed an agreement to acquire MESA Pharmacy, Inc. as part of its new strategy to become a dominant player in the delivery of compounded pharmaceutical products to consumers.
PALO ALTO, CA, Oct. 29, 2013 /PRNewswire/ - The PAWS Pet Company, Inc. (OTCQB:PAWS) has executed an agreement to acquire MESA Pharmacy, Inc. (MESA) from its parent, Pharmacy Development Corp. in exchange for preferred stock. PAWS will be filing a report on Form 8-K within the next few days. Previously, the Company had announced that it and PDC had determined to enter into a joint venture, however progress on PDC/MESA's audit has been much better than anticipated and the parties have determined that purchasing MESA would be better for all of the parties and their respective shareholders.
MESA focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and clinics. MESA has developed a series of topical ointments, in different strengths, that provide the pain relief doctors seek.
During the current month, according to MESA, it has received more than $3,400,000 in orders and filled more than $1,500,000 in actual prescriptions. MESA believes that it is on track to exceed $25,000,000 in revenues during fiscal year 2014 with much greater revenues a very real possibility.
PDC will be paid a royalty on collection for each prescription filled by MESA as well as receiving 500,000 shares of PAWS Series D Convertible Preferred Stock. The parties will begin the process of transferring MESA's license from PDC to PAWS as soon as possible and the transaction is intended to close upon the issuance of a new California pharmacy license or sooner. PDC has the right to appoint three members to the Board of Directors as soon as the new license is issued and the audit of MESA's operations is completed.
Furthermore, the holders of a majority of the Company's Series B Convertible Preferred Stock shares have agreed to vote to reduce the maximum conversion rate in order to offset the new Series D stock, on a fully diluted basis.
Additionally, PAWS intends to spin off its remaining airline related properties, freeing the Company of much of its debt and further intends to settle most of its remaining debt in the very near future.
"We are excited about these developments, for our company and our shareholders, and we believe with MESA's great team, a great foundation for future growth is set", said Dan Wiesel CEO of The PAWS Pet Company. He continued, "With the execution of this agreement, the way forward for PAWS is clear and we will now focus on completing the licensing process, domesticating the Company in Nevada and changing our name to Praxsyn Corporation."
Fantastic news- This PPS will be long gone
So what you are saying is, we will get the financials we're all waiting for just in time for CHRISTMAS! :)
Interesting action today. I never did like these large spreads- They can cause the action to be rather deceiving.
still about 5 mil at 29
ill be getting the full share report today or tomorrow
No- when you use the find function it tells you how many results it has populated. There is one extra result so the total is 199. No copying or pasting, just a simple 5 second operation
I like my method better, much quicker :) lol
Yes but look at it this way- if .15 a share is an actual possibility based purely on calculations- doing even a third of that, .05, shouldnt be an issue, right?
Yes but a simple and 100% accurate way to find the number of locations would be to use the find function and look up the one thing every store listing has in common- Which in this case would be miles
To be clear, first off- I do not think an R/S will happen even within the next full calender year.
And if at that point it does happen, people would be panicking for really no reason. If an R/S is justified and implemented correctly, it is a purely psychological fear with nothing truly negative about it.
But that is not something we need to worry about, MINE is truly a GOLD MINE. Now lets make us some $$$$
If we can move up like this on a friday, monday could be a very good day for us :)
No measure of R/S would allow us to uplist at this price so you probably just shouldnt worry about it
From the sounds of it, we probably are in over 250 stores then.
Get updating the tracker Level 5!
I also count 199 using that method, and I know 100% it isnt a miscount since its the computer counting